PRIMARY STUDY

Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse

Key Findings:  The antioxidant and anti-inflammatory effects of cannabis or cannabinoid-based therapeutics may improve ulcerative colitis and Crohn's Disease but more clinical trials are needed to establish clinical treatment criteria.

Type of Study:  Meta-analysis

Study Result:  Positive

Study Location(s):  Brazil

Year of Pub:  2020


Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabinoid (unspecified)

Phytocannabinoid Source:  Unspecified